Breast Cancer Under 40: Why Every Woman Needs to Know Her BRCA Status
Diagnosed with breast cancer at 26, learning I had a BRCA2 mutation gave me answers. Discover how genetic testing empowers young women with options.
Explore our blog posts about the importance of hereditary cancer testing and reproductive carrier screening.
Diagnosed with breast cancer at 26, learning I had a BRCA2 mutation gave me answers. Discover how genetic testing empowers young women with options.

Diagnosed with breast cancer at 26, learning I had a BRCA2 mutation gave me answers. Discover how genetic testing empowers young women with options.
Click through to uncover the in-depth disscussion, expert insights, and valuable context that paint the complete picture. Check out the full story to see the entire article.


1 in 40 Ashkenazi Jews carries a BRCA mutation — 10x the general population. Learn your cancer risks, prevention options, and how to get tested through jscreen.
Click through to uncover the in-depth disscussion, expert insights, and valuable context that paint the complete picture. Check out the full story to see the entire article.


Learn about 19+ Ashkenazi Jewish genetic diseases, carrier rates, and who should get tested. Order an at-home screening kit from jscreen — no doctor’s appointment needed.
Click through to uncover the in-depth disscussion, expert insights, and valuable context that paint the complete picture. Check out the full story to see the entire article.


Understanding your carrier status is a powerful act of preparation for your family’s future. Explore this guide to learn what being a carrier actually means for Jewish families and the proactive steps you can take today.
Click through to uncover the in-depth disscussion, expert insights, and valuable context that paint the complete picture. Check out the full story to see the entire article.
.webp)

1 in 4 Ashkenazi Jews is a carrier for a genetic disease. Learn how jscreen’s at-home screening and counseling empower Jewish families to plan with confidence.
Click through to uncover the in-depth disscussion, expert insights, and valuable context that paint the complete picture. Check out the full story to see the entire article.


After a uterine cancer diagnosis at 30, Jackie used her MSH2 Lynch syndrome mutation as a roadmap for health. Read her story and learn how genetic testing and jscreen empower prevention.
Click through to uncover the in-depth disscussion, expert insights, and valuable context that paint the complete picture. Check out the full story to see the entire article.